Clinical Obstetrics: HTN Flashcards
Plasma volume / Blood volume
Normal CV Changes in Pregnancy
Increase w/ weeks gestation
Blood volume increases ~60%
Red cell mass
Normal CV Changes in Pregnancy
Increases w/ weeks gestation
Hematocrit
Normal CV Changes in Pregnancy
Decreases w/ weeks gestation
* Physiological anemia
Greater increase in plasma volume than red cell mass
Heart rate
Normal Physiological Changes in Pregnancy
Increases w/ weeks gestation
HR increases 10-15 bpm
Stroke volume
Normal Physiological Changes in Pregnancy
Increases w/ weeks gestation
Cardiac output
* Undetected heart problems may present during pregnancy due to increased demand on heart
Normal Physiological Changes in Pregnancy
Increases w/ weeks gestation
Normal CO = 5 L/min; at 20 weeks gestation = 7 L/min
Blood pressure
Normal Physiological Changes in Pregnancy
Decreases w/ weeks gestation
Systemic vascular resistance (SVR)
Normal Physiological Changes in Pregnancy
Decreases w/ week gestation
* Vasopressor (Ang II) resistance during pregnancy
* Increased endothelium-dependent factors: NO
* Upregulated by estradiol & vasodilatory prostaglandins (PGI2)
Peripheral vasodilation leads to 25-30% decrease in SVR
Hypertensive disorders of pregnancy
- Gestational HTN
- Preeclampsia
- Eclampsia
- Chronic HTN
SBP >140 or DBP >90 mm Hg
* >20 weeks gestation
* Absence of proteinuria, systemic signs/symptoms
Gestational HTN
- SBP >140 or DBP >90 mm Hg
- > 20 weeks gestation
- Proteinuria with or without signs/symptos
- Preeclampsia signs/Sx/labs w/o proteinuria
Preeclampsia
- SBP > 140 or DBP > 90
- Pregestational or <20 wks gestation
Chronic HTN
Physiological changes of pregnancy should resolve by 6 weeks postpartum
Blood Pressure
* SBP >140 mm Hg OR DBP >90 mm Hg on 2 occasions at least 4 hrs apart after 20 wks gestation in woman w/ previously normal BP
OR
* SBP >160 mm Hg OR DBP >110 mm Hg confirmed within short interval (15 min)
Proteinuria
* >300 mg per 24-hour urine collection
OR
* Protein/creatinine ratio >0.3
OR
* Dipstick reading of 2+ (used only if other quantitative methods not available)
Preeclampsia
- Nulliparity
- Multifetal gestations (i.e., twins)
- Chronic HTN
- Pregestational / gestational diabetes
- SLE
- Pregestational BMI >30
- Antiphospholipid antibody syndrome
- Maternal age >35 years
- Kidney disease
- Thrombophilia
- Assisted reproductive technology
- Obstructive sleep apnea
Risk Factors
Preeclampsia
Two-stage theory of pre-eclampsia
Etiology
- Lack of remodeling of spiral arteriole intima by cytotrophoblasts leading to less capacitance, decreased blood flow, and hypoxia
* Remodeling normally dilates spiral arterioles, results in lower resistance, greater capacitance, increased blood flow - Placental hypoxia damages syncytium
* Increased maternal oxidative stress and endothelial & immunological dysfunction leading to maternal end-organ damage
Mediators of preeclampsia
- Hypoxia results in upregulation of sFlt1
- Increased sFlt1 reduces free VEGF & PIGF
- Decreased free VEGF & PIGF results in endothelial dysfunction of maternal blood vessel
sFlt1: soluble EGF transporter
Maternal end-organ damage in preeclampsia
- HTN
- Glomerular dysfunction
- Proteinuria
- Brain & liver edema
- Coagulation abnormalities
Preeclampsia
Etiology
Vasospasm
* Uterine vessels (two-stage theory)
* Inadequate maternal vascular response to trophoblast-mediated vascular changes
* Endothelial damage
* Hemostasis
* Prostanoid balance
* PGI2:TXA2 balance shifted to favor TXA2
* TXA2 promotes: vasoconstriction; platelet aggregation
* Endothelium-derived factors
* Decreased NO in pts w/ preeclampsia resulting in vasoconstriction
* Lipid peroxide, free radicals & antioxidants
* Increase in preeclampsia resulting in vascular injury
Preeclampsia
Pathophysiology
Mediated by systemic vasospasm
* Cardiovascular effects
* Hematologic effects
* Neurologic effects
* Pulmonary effects
* Renal effects
* Fetal effects
Cardiovascular effects of vasospasm
Pathophysiology
- Hypertension
- Increased CO
- Increased SVR
Hematologic effects of vasospasm
Pathophysiology
- Volume contraction / hypovolemia
- Elevated hematocrit
- Thrombocytopenia
- Microangiopathic hemolytic anemia
- Third spacing of fluid
- Low oncotic pressure
Neurologic effects of vasospasm
Pathophysiology
- Hyperreflexia
- Headache
- Cerebral edema
- Seizures (eclampsia)
- PRES radiological findings
Pulmonary effects of vasospasm
Pathophysiology
- Capillary leak
- Reduced colloid osmotic pressure
- Pulmonary edema
Renal effects of vasospasm
Pathophysiology
- Decreased GFR
- Glomerular endotheliosis
- Proteinuria
- Oliguria
- Acute tubular necrosis
Fetal effects of vasospasm
Pathophysiology
- Placental abruption
- Fetal growth restriction
- Oligohydramnios
- Fetal distress
- Increased perinetal morbidity & mortality
- Headache
- Visual changes
- Epigastric / RUQ pain
Symptoms
Severe preeclampsia
- SBP >160 or DBP >110
- Papilledema
- Pulmonary edema
Signs
Severe preeclampsia
- Platelets: < 100,000 x 10^9 /L
- AST, ALT: elevated (>2x normal)
- Serum creatinine: >1.1 mg/dL
- Hemolysis
- Abnormal coagulation: increased PT, PTT
Labs
Severe preeclampsia
Defined as severe preeclampsia with new onset tonic-clonic, focal or multifocal seizures in absence of other causative conditions
Eclampsia
Other cause: epilepsy, cerebral ischemia, intracranial hemorrhage, drugs
Eclampsia
Epidemiology
Incidence (US): 1/1,000 deliveries
Mortality: 1% developed world; 15% developing world
- LDH: >600 IU/L
- AST & ALT: >2x ULN
- Platelets: < 100,000
HELLP syndrome
HELLP: Hemolysis, Elevated Liver Enzynes, Low Platelets
HELLP syndrome
Epidemiology
20% of women with severe preeclampsia
* Occurs in young women, early in pregnancy
HELLP syndrome
Potential Complications
- Placental abruption
- Renal failure
- Subcapsular hepatic hematoma
- Preterm delivery
- Fetal / maternal death
- Recurrent preeclampsia
Non-severe preeclampsia
Approach to Therapy
Conservative management
* Modified bedrest (rest at home; no activity)
* BP monitoring 2-3x/day
* Call MD if any Sx of headache, visual changes, or decreased fetal movement
* Biweekly MD visit
* Weekly labs
* Biweekly fetal well-being tests (sonogram, NST)
Severe preeclampsia
Approach to Therapy
Delivery
* Pitocin: induce labor
* Magnesium sulfate: prevent seizures
* Antihypertensives (some cases)
MoA: Pitocin
Severe Preeclampsia Treatment
- Oxytocin stimulates Ca2+-mediated activation of myometrial receptors
- Also causes release of Ca2+ from sarcoplasmic reticulum
- Activation of Ca2+ receptors induces contraction
Pitocin = oxytocin analog
MoA: Magnesium Sulfate
Severe Preeclampsia Treatment
- CNS depression
- Mg2+ competes with Ca2+ for calcium channels blocking intracellular flow of Ca2+ needed to initiate neuronal firing
- Raises threshold for neuronal triggering of seizure activity
- Antagonistic effects of Mg2+ can also affect cerebral endothelium that forms BBB
- Decreased cell calcium inhibits endothelial contraction & opening of tight junctions
- Mg2+ competes with Ca2+ for calcium channels blocking intracellular flow of Ca2+ needed to initiate neuronal firing
- Increased blood flow to CNS
- Small vessel vasodilation
- Loss of deep tendon reflexes (DTRs)
- Respiratory depression
- Cardiac arrest
Symptoms
Magnesium sulfate toxicity
* Loss of DTRs: >10 mEq/L
* RD: >15 mEq/L
* CA: >20 mEq/L
Recommended Mg levels: 4-7 mEq/L; monitor DTRs
Indication for antihypertensives in preeclampsia
Approach to Therapy
Severe HTN: SBP >160 or DBP >110
Optimal intervention to prevent deaths due to stroke in women with preeclampsia
Blood pressure control
First-line antihypertensive agents for preeclampsia
Approach to Therapy
- Labetalol IV
- Hydralazine IV
- Nifedipine PO: if no IV route available
MoA: Labetolol
Severe Preeclampsia BP Control
- Non-specific antiadrenergic agent
- Alpha1-blocker: vasodilation
- Decreases SVR
- Beta-blocker: prevents reflex tachycardia
- Decreases BP
- Flushing
- Light headedness
- Palpitations
- Scalp tingling
Symptoms
Labetolol side effects
Severe Preeclampsia BP Control
MoA: Hydralazine
Severe Preeclampsia BP Control
- Activates arteriolar endothelium receptors & induces release of NO
- Promotes vasodialtion
- Decreases SVR
- Reflex tachycardia
- Flushing
- Nausea
- Salt & water retention
- Drug-induced SLE
Symptoms
Hydralazine side effects
Severe Preeclampsia BP Control
- Reflex tachycardia
- Flushing
- Nausea
- Salt & water retention
- Drug-induced SLE
Symptoms
Hydralazine side effects
Severe Preeclampsia BP Control
MoA: Nifedipine
Severe Preeclampsia BP Control
- Blocks Ca2+ channels & reduces intracellular Ca2+ in vascular smooth muscle
- Prevents contraction of vascular smooth muscle
- Promotes vasodilation
- Decreases SVR
Chronic HTN & superimposed preeclampsia
Approach to Diagnosis
- Chronic HTN
- HTN diagnosed pregestation or <20 wks gestation
OR - HTN first diagnosed during pregnancy & does not resolve in postpartum period
- HTN diagnosed pregestation or <20 wks gestation
- Superimposed preeclampsia
- Preeclampsia w/ Hx of HTN before pregnancy or <20 wks gestation
Chronic HTN & superimposed preeclampsia
Approach to Diagnosis
- Chronic HTN
- HTN diagnosed pregestation or <20 wks gestation
OR - HTN first diagnosed during pregnancy & does not resolve in postpartum period
- HTN diagnosed pregestation or <20 wks gestation
- Superimposed preeclampsia
- Preeclampsia w/ Hx of HTN before pregnancy or <20 wks gestation
`